2-46356142-C-CCT
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_001430.5(EPAS1):c.218-8_218-7dup variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,374,212 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 3 hom., cov: 23)
Exomes 𝑓: 0.0012 ( 8 hom. )
Consequence
EPAS1
NM_001430.5 splice_polypyrimidine_tract, intron
NM_001430.5 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.628
Genes affected
EPAS1 (HGNC:3374): (endothelial PAS domain protein 1) This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 2-46356142-C-CCT is Benign according to our data. Variant chr2-46356142-C-CCT is described in ClinVar as [Likely_benign]. Clinvar id is 336244.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 483 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPAS1 | NM_001430.5 | c.218-8_218-7dup | splice_polypyrimidine_tract_variant, intron_variant | ENST00000263734.5 | NP_001421.2 | |||
EPAS1 | XM_011532698.3 | c.257-8_257-7dup | splice_polypyrimidine_tract_variant, intron_variant | XP_011531000.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPAS1 | ENST00000263734.5 | c.218-8_218-7dup | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001430.5 | ENSP00000263734 | P1 | |||
EPAS1 | ENST00000449347.5 | c.218-8_218-7dup | splice_polypyrimidine_tract_variant, intron_variant | 3 | ENSP00000406137 | |||||
EPAS1 | ENST00000463191.1 | n.29_30dup | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
EPAS1 | ENST00000475822.1 | n.409-8_409-7dup | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00333 AC: 482AN: 144834Hom.: 3 Cov.: 23
GnomAD3 genomes
AF:
AC:
482
AN:
144834
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00117 AC: 1433AN: 1229260Hom.: 8 Cov.: 34 AF XY: 0.00106 AC XY: 652AN XY: 617610
GnomAD4 exome
AF:
AC:
1433
AN:
1229260
Hom.:
Cov.:
34
AF XY:
AC XY:
652
AN XY:
617610
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00333 AC: 483AN: 144952Hom.: 3 Cov.: 23 AF XY: 0.00329 AC XY: 231AN XY: 70260
GnomAD4 genome
AF:
AC:
483
AN:
144952
Hom.:
Cov.:
23
AF XY:
AC XY:
231
AN XY:
70260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
EPAS1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 31, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Familial erythrocytosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at